|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600123299 |
|
最近更新日期: Date of Last Refreshed on: |
2026-04-23 17:07:02 |
|
注册时间: Date of Registration: |
2026-04-23 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
孤独症谱系障碍患儿家庭导航:干预方案开发及有效性评价的研究计划 |
|
Public title: |
Family Navigation for Children at Risk for Autism Spectrum Disorder: A Protocol of Program Development and Effectiveness Evaluation |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
家庭导航视角下孤独症谱系障碍患儿诊疗延迟干预效果评价 |
|
Scientific title: |
Evaluation of the intervention effect on the delayed diagnosis and treatment of children with autism spectrum disorder from the perspective of family navigation |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
李飞 |
研究负责人: |
李飞 |
|
Applicant: |
Li Fei |
Study leader: |
Li Fei |
|
申请注册联系人电话: Applicant telephone: |
+86 189 8326 6584 |
研究负责人电话: Study leader's telephone: |
+86 189 8326 6584 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
Singlifei@163.com |
研究负责人电子邮件: Study leader's E-mail: |
1374515811@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国广东省广州市天河区天河路600号 |
研究负责人通讯地址: |
中国广东省广州市天河区天河路600号 |
|
Applicant address: |
600 Tianhe Road,Guangzhou,Guangdong,China |
Study leader's address: |
600 Tianhe Road,Guangzhou,Guangdong,China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
中山大学附属第三医院 |
||
|
Applicant's institution: |
The Third Affiliated Hospital of Sun Yat-sen University |
||
|
研究负责人所在单位: |
中山大学附属第三医院 |
||
|
Affiliation of the Leader: |
The Third Affiliated Hospital of Sun Yat-sen University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
中大附三医伦II2026-119-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中山大学附属第三医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2026-03-30 00:00:00 |
||
|
伦理委员会联系人: |
黄凯祺 |
||
|
Contact Name of the ethic committee: |
Huang Kaiqi |
||
|
伦理委员会联系地址: |
中国广东省广州市天河区天河路600号 |
||
|
Contact Address of the ethic committee: |
600 Tianhe Road,Guangzhou,Guangdong,China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 20 8525 3302 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
中山大学附属第三医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Third Affiliated Hospital of Sun Yat-sen University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国广东省广州市天河区天河路600号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
600 Tianhe Road,Guangzhou,Guangdong,China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
广东省护理学会、广东省岭南南丁格尔护理研究院基金项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
Fund Project of Guangdong Nursing Association and Guangdong Lingnan Nightingale Nursing Research Institute |
||||||||||||||||||||||
|
Target disease: |
Autism Spectrum Disorder |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
评价自行开发的ASD患儿家庭导航服务模式的应用效果,包括家庭导航服务模式对ASD患儿诊断-干预时间间隔、早期干预发起率,以及父母养育压力、自我效能等结局的影响。 |
||||||||||||||||||||||
|
Objectives of Study: |
Evaluate the effectiveness of the home navigation service model developed for children with ASD, including its impact on the time between diagnosis and intervention, the rate of early intervention initiation, as well as parental stress and self-efficacy among other outcomes. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
患儿的纳入标准:①年龄为6岁及以下;②我院首次就诊并正式确诊ASD;③既往未在院外确诊ASD;④既往未在机构接受正式的ASD相关早期干预;⑤常驻广州城区。 父母的纳入标准为:①承担患儿的主要照护任务(连续照护时间≥6个月);②父母年龄为20-65岁;③父母知情同意并自愿参与。 |
||||||||||||||||||||||
|
Inclusion criteria |
Inclusion criteria for children: 1. Age 6 years or younger; 2. First visit to our hospital with a formal diagnosis of ASD; 3. No previous diagnosis of ASD outside our hospital; 4. No prior formal early intervention related to ASD at any institution; 5. Resident in the urban area of Guangzhou. Inclusion criteria for parents: 1. Responsible for primary care of the child (continuous care period ≥ 6 months); 2. Parents’ age between 20 and 65 years; 3. Written consent and voluntary participation from both parents. |
||||||||||||||||||||||
|
排除标准: |
①患儿入组前已在院外确诊;②患儿入组前已发起康复干预。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.The child was diagnosed outside the hospital before enrollment; 2.Rehabilitation interventions had already begun before the child was enrolled. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-04-23 00:00:00至 To 2027-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2026-04-24 00:00:00 至 To 2027-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
分配组别的随机数字将由未参与干预的研究人员使用IBS SPSS statistics版本26.0生成 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The random numbers assigned to each group will be generated by researchers who did not participate in the intervention, using IBS SPSS Statistics version 26.0. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
开放标签 |
|
Blinding: |
Open labling |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Not shared |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
采用自行设计病例记录表(Case Record Form, CRF)进行数据的收集。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection was conducted using a self-designed Case Record Form (CRF). |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |